Evidence map›Paper›PMID 37510126›Full record

ReviewDiagnostics (Basel, Switzerland)2023

The Impact of Heart Rate Variability Monitoring on Preventing Severe Cardiovascular Events.

Ana-Maria Turcu, Adina Carmen Ilie, Ramona Ștefăniu, Sabinne Marie Țăranu, Ioana Alexandra Sandu, Teodora Alexa-Stratulat, Anca Iuliana Pîslaru, Ioana Dana Alexa

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Mitigating fraud in a fully decentralized clinical trial of a digital health intervention.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Technological Advances in the Diagnosis of Cardiovascular Disease: A Public Health Strategy.International journal of environmental research and public health · 2024
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ana-Maria TurcuDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Adina Carmen IlieDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-9152-8534
Ramona ȘtefăniuDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Sabinne Marie ȚăranuDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ioana Alexandra SanduDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Teodora Alexa-StratulatDepartment of Medical Oncology-Radiotherapy, Faculty of Medicine, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0003-2696-9568
Anca Iuliana PîslaruDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Ioana Dana AlexaDepartment of Medical Specialties II, Grigore T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Grigore T. Popa University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in the incidence of cardiovascular diseases worldwide raises concerns about the urgent need to increase definite measures for the self-determination of different parameters, especially those defining cardiac function. Heart rate variability (HRV) is a non-invasive method used to evaluate autonomic nervous system modulation on the cardiac sinus node, thus describing the oscillations between consecutive electrocardiogram R-R intervals. These fluctuations are undetectable except when using specialized devices, with ECG Holter monitoring considered the gold standard. HRV is considered an independent biomarker for measuring cardiovascular risk and for screening the occurrence of both acute and chronic heart diseases. Also, it can be an important predictive factor of frailty or neurocognitive disorders, like anxiety and depression. An increased HRV is correlated with rest, exercise, and good recovery, while a decreased HRV is an effect of stress or illness. Until now, ECG Holter monitoring has been considered the gold standard for determining HRV, but the recent decade has led to an accelerated development of technology using numerous devices that were created specifically for the pre-hospital self-monitoring of health statuses. The new generation of devices is based on the use of photoplethysmography, which involves the determination of blood changes at the level of blood vessels. These devices provide additional information about heart rate (HR), blood pressure (BP), peripheral oxygen saturation (SpO

Indexed as

heart rate variabilitynovel wearablewearable devices

Identifiers

PMID37510126
PMCPMC10378206
OpenAlexW4384616479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.